The relationship between serial measurements of the level of a bladder tumor associated antigen and the potential for recurrence

Journal of Urology

Volumn 161, Issue 1, 1999, Pages 57-61

  Blumenstein, Brent A ^a   Ellis, William J ^a   Ishak, Laura M ^a  

^a NONE

Author keywords

Antigens; Bladder neoplasms; Tumor markers, biological

Indexed keywords

TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER RECURRENCE; CANCER STAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RATING SCALE; TUMOR RECURRENCE; URINALYSIS;

EID: 0032830261     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62061-5     Document Type: Article

References (9)

1. Whitmore, W. F., Jr.: Bladder cancer: an overview. CA Cancer J. Clin., 38: 213, 1988.
2. Badalament, R. A., Hermansen, D. K., Kimmel, M., Gay, H., Herr, H. W., Fair, W. K., Whitmore, W. T., Jr. and Melamed, M. R.: The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer, 60: 1423, 1987.
3. Murphy, W. M.: Current status of urinary cytology in the evaluation bladder neoplasms. Hum. Path., 21: 886, 1990.
4. Ellis, W. J., Blumenstein, B. A., Ishak, L. M., Enfield, D. L. and the Multicenter Study Group: Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA Test in patients with recurrent bladder tumors. Urology, 50: 882, 1997.
5. Kinders, R., Jones, T., Root, R., Murchison, H., Bruce, C., Williams, L. and Hass, G. M.: Human bladder tumor antigen is a member of the RCA (regulators of complement activation) gene family. J. Urol., part 2, 157: 28, abstract 110, 1997.
6. Kinders, R., Root, R., Jones, T., Bruce, C. L. and Hass, G. M.: Complement factor H-related proteins are expressed in bladder cancers. Proc. Amer. Assn. Cancer Res., 38: 29, 1997.
7. Cox, D. R.: Regression models and life tables. J. Roy. Stat. Soc., 34: 187, 1972.
8. Gail, M. H.: Evaluating serial cancer marker studies in patients at risk of recurrent disease. Biometrics, 37: 67, 1981.
9. Lamm, D. L., Blumenstein, B., Sarosdy, M., Grossman, H. B. and Crawford, E. D.: Significant long-term patient benefit with BCG maintenance therapy: a Southwest Oncology Group study. J. Urol., part 2, 157: 213, abstract 831, 1997.